Perspectives from FDA's Leadership - Sentinel Initiative Public Workshop

preview_player
Показать описание

  1. Duke Margolis
Рекомендации по теме
Nikolay P. Nikolov: 0:20:46

Nikolay P. Nikolov: Clinical Trials, an FDA perspective

Featured Fireside Chat: 1:10:39

Featured Fireside Chat: FDA Perspective

FDA Releases Laboratory-Developed 0:01:47

FDA Releases Laboratory-Developed Tests Final Rule - Thought Leaders in Health Law®

What RA/QA/Clinical Leaders 0:43:08

What RA/QA/Clinical Leaders Should Expect From the FDA in 2021

Global Regulatory Roundtable: 1:27:22

Global Regulatory Roundtable: FDA and Notified Body Perspectives

FDA RWE Regulatory 0:31:18

FDA RWE Regulatory Perspective

Crisis: Alert FDA 0:00:36

Crisis: Alert FDA About ZepBound & Mounjaro Shortages

FDA In Violation 0:00:52

FDA In Violation Of Law With NMN Ban

FDA & Industry 1:33:34

FDA & Industry Panel Discussion: Biomanufacturing Innovation in a Regulated Industry

RFK Jr. vows 0:03:39

RFK Jr. vows to clear out entire departments at FDA

PN Perspectives: The 0:09:42

PN Perspectives: The FDA, Social Media and the Future of Health Care Communications

FDA Insides by 0:47:20

FDA Insides by Jyoti Sardesai – Navigating Challenges and Driving Change

Tips for Submitting 0:28:46

Tips for Submitting Drug Proposals to the FDA | Ashley Preston

FDA and CDC 0:02:34

FDA and CDC leaders explain why Johnson and Johnson vaccinations are pausing

FDA Acting Chief 0:03:43

FDA Acting Chief Scientist Jacqueline O'Shaughnessy, PhD, at the 2022 Annual Public Meeting

The FDA Perspective 0:38:28

The FDA Perspective on Hepatitis C Drug Resistance | Patrick Harrington, PHD

The FDA's Progressive 0:37:40

The FDA's Progressive Appeal ft. Allan Shaw

FDA’s KASA Initiative 1:13:57

FDA’s KASA Initiative Criticality of Quality Oversight and Risk Mitigation

ACRO on Innovation 0:03:57

ACRO on Innovation in Clinical Trials at the FDA

Medcrypt Webinar: Prioritizing 0:58:02

Medcrypt Webinar: Prioritizing Security - Insights from Security Leaders on Adapting to FDA Guidance

Dr Mark Fleury 0:03:21

Dr Mark Fleury Highlights ACS CAN’s Involvement in FDA’s Patient-Focused Drug Development Initiative...

Meeting the Requirements 0:59:10

Meeting the Requirements of the UDI Final Rule, an FDA Perspective

View and Update 0:18:52

View and Update from FDA

What we know 0:08:42

What we know about the next leaders of the CDC, NIH, FDA, and Medicare & Medicaid